טוען...
Effectiveness of tranexamic acid in reducing blood loss during cytoreductive surgery for advanced ovarian cancer
BACKGROUND: Ovarian cancer is the third most common gynaecological cancer worldwide, with an age‐standardised incidence rate of 6.1 per 10,000 women. Standard therapy for advanced epithelial ovarian cancer (EOC) includes a combination of cytoreductive surgery and platinum‐based chemotherapy. Cytored...
שמור ב:
| הוצא לאור ב: | Cochrane Database Syst Rev |
|---|---|
| Main Authors: | , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
John Wiley & Sons, Ltd
2016
|
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6353072/ https://ncbi.nlm.nih.gov/pubmed/26801659 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD011732.pub2 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|